1
|
Gallet P, Oussalah A, Pouget C, Dittmar G, Chery C, Gauchotte G, Jankowski R, Gueant JL, Houlgatte R. Integrative genomics analysis of nasal intestinal-type adenocarcinomas demonstrates the major role of CACNA1C and paves the way for a simple diagnostic tool in male woodworkers. Clin Epigenetics 2021; 13:179. [PMID: 34563241 PMCID: PMC8467244 DOI: 10.1186/s13148-021-01122-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2021] [Accepted: 06/27/2021] [Indexed: 11/23/2022] Open
Abstract
Background Nasal intestinal-type adenocarcinomas (ITAC) are strongly related to chronic wood dust exposure: The intestinal phenotype relies on CDX2 overexpression but underlying molecular mechanisms remain unknown. Our objectives were to investigate transcriptomic and methylation differences between healthy non-exposed and tumor olfactory cleft mucosae and to compare transcriptomic profiles between non-exposed, wood dust-exposed and ITAC mucosa cells.
Methods We conducted a prospective monocentric study (NCT0281823) including 16 woodworkers with ITAC, 16 healthy exposed woodworkers and 13 healthy, non-exposed, controls. We compared tumor samples with healthy non-exposed samples, both in transcriptome and in methylome analyses. We also investigated wood dust-induced transcriptome modifications of exposed (without tumor) male woodworkers’ samples and of contralateral sides of woodworkers with tumors. We conducted in parallel transcriptome and methylome analysis, and then, the transcriptome analysis was focused on the genes highlighted in methylome analysis. We replicated our results on dataset GSE17433. Results Several clusters of genes enabled the distinction between healthy and ITAC samples. Transcriptomic and IHC analysis confirmed a constant overexpression of CDX2 in ITAC samples, without any specific DNA methylation profile regarding the CDX2 locus. ITAC woodworkers also exhibited a specific transcriptomic profile in their contralateral (non-tumor) olfactory cleft, different from that of other exposed woodworkers, suggesting that they had a different exposure or a different susceptibility. Two top-loci (CACNA1C/CACNA1C-AS1 and SLC26A10) were identified with a hemimethylated profile, but only CACNA1C appeared to be overexpressed both in transcriptomic analysis and in immunohistochemistry. Conclusions Several clusters of genes enable the distinction between healthy mucosa and ITAC samples even in contralateral nasal fossa thus paving the way for a simple diagnostic tool for ITAC in male woodworkers. CACNA1C might be considered as a master gene of ITAC and should be further investigated. Trial registration: NIH ClinicalTrials, NCT0281823, registered May 23d 2016, https://www.clinicaltrials.gov/NCT0281823. Supplementary Information The online version contains supplementary material available at 10.1186/s13148-021-01122-5.
Collapse
Affiliation(s)
- Patrice Gallet
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France. .,ENT Department, CHRU NANCY, 54511, Vandoeuvre-lès-Nancy, France.
| | - Abderrahim Oussalah
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France
| | - Celso Pouget
- Pathology Department, CHRU NANCY, 54511, Vandoeuvre-lès-Nancy, France
| | - Gunnar Dittmar
- Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - Celine Chery
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France
| | - Guillaume Gauchotte
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France
| | - Roger Jankowski
- ENT Department, CHRU NANCY, 54511, Vandoeuvre-lès-Nancy, France
| | - Jean Louis Gueant
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France
| | - Rémi Houlgatte
- INSERM U1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, 54000, Nancy, Vandoeuvre-lès-Nancy, France
| |
Collapse
|
2
|
Bazile J, Jaffrezic F, Dehais P, Reichstadt M, Klopp C, Laloe D, Bonnet M. Molecular signatures of muscle growth and composition deciphered by the meta-analysis of age-related public transcriptomics data. Physiol Genomics 2020; 52:322-332. [PMID: 32657225 DOI: 10.1152/physiolgenomics.00020.2020] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
The lean-to-fat ratio is a major issue in the beef meat industry from both carcass and meat production perspectives. This industrial perspective has motivated meat physiologists to use transcriptomics technologies to decipher mechanisms behind fat deposition within muscle during the time course of muscle growth. However, synthetic biological information from this volume of data remains to be produced to identify mechanisms found in various breeds and rearing practices. We conducted a meta-analysis on 10 transcriptomic data sets stored in public databases, from the longissimus thoracis of five different bovine breeds divergent by age. We updated gene identifiers on the last version of the bovine genome (UCD1.2), and the 715 genes common to the 10 studies were subjected to the meta-analysis. Of the 238 genes differentially expressed (DEG), we identified a transcriptional signature of the dynamic regulation of glycolytic and oxidative metabolisms that agrees with a known shift between those two pathways from the animal puberty. We proposed some master genes of the myogenesis, namely MYOG and MAPK14, as probable regulators of the glycolytic and oxidative metabolisms. We also identified overexpressed genes related to lipid metabolism (APOE, LDLR, MXRA8, and HSP90AA1) that may contribute to the expected enhanced marbling as age increases. Lastly, we proposed a transcriptional signature related to the induction (YBX1) or repression (MAPK14, YWAH, ERBB2) of the commitment of myogenic progenitors into the adipogenic lineage. The relationships between the abundance of the identified mRNA and marbling values remain to be analyzed in a marbling biomarkers discovery perspectives.
Collapse
Affiliation(s)
- Jeanne Bazile
- INRAE, UMR Herbivores, Université Clermont Auvergne, VetAgro Sup, Saint-Genès-Champanelle, France
| | - Florence Jaffrezic
- INRAE, UMR1313 Génétique Animale et Biologie Intégrative, Jouy-en-Josas, France
| | - Patrice Dehais
- Plate-forme bio-informatique Genotoul, Mathématiques et Informatique Appliquées de Toulouse, INRAE, Castanet Tolosan, France.,SIGENAE, GenPhySE, Université de Toulouse, INRAE, ENVT, Castanet Tolosan, France
| | - Matthieu Reichstadt
- INRAE, UMR Herbivores, Université Clermont Auvergne, VetAgro Sup, Saint-Genès-Champanelle, France
| | - Christophe Klopp
- Plate-forme bio-informatique Genotoul, Mathématiques et Informatique Appliquées de Toulouse, INRAE, Castanet Tolosan, France.,SIGENAE, GenPhySE, Université de Toulouse, INRAE, ENVT, Castanet Tolosan, France
| | - Denis Laloe
- INRAE, UMR1313 Génétique Animale et Biologie Intégrative, Jouy-en-Josas, France
| | - Muriel Bonnet
- INRAE, UMR Herbivores, Université Clermont Auvergne, VetAgro Sup, Saint-Genès-Champanelle, France
| |
Collapse
|
3
|
Safar R, Houlgatte R, Le Faou A, Ronzani C, Wu W, Ferrari L, Dubois-Pot-Schneider H, Rihn BH, Joubert O. Encapsulation of S-nitrosoglutathione: a transcriptomic validation. Drug Dev Ind Pharm 2018; 45:423-429. [DOI: 10.1080/03639045.2018.1546313] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Ramia Safar
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Rémi Houlgatte
- INSERM U1256, Université de Lorraine, Faculté de Médecine, Nancy, France
- Hematology Laboratory, University Hospital of Nancy, Nancy, France
| | - Alain Le Faou
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
- Faculté de Médecine, Université de Lorraine, Nancy, France
| | - Carole Ronzani
- UMR 7199 CNRS, Université de Strasbourg, Faculté de Pharmacie, Strasbourg, France
| | - Wen Wu
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Luc Ferrari
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
- Institut Jean-Lamour, UMR CNRS 7198, Université de Lorraine, Nancy, France
| | | | - Bertrand H. Rihn
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
- Institut Jean-Lamour, UMR CNRS 7198, Université de Lorraine, Nancy, France
| | - Olivier Joubert
- EA 3452 CITHÉFOR, Université de Lorraine, Faculté de Pharmacie, Nancy, France
- Institut Jean-Lamour, UMR CNRS 7198, Université de Lorraine, Nancy, France
| |
Collapse
|
4
|
Espitia O, Chatelais M, Steenman M, Charrier C, Maurel B, Georges S, Houlgatte R, Verrecchia F, Ory B, Lamoureux F, Heymann D, Gouëffic Y, Quillard T. Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification. PLoS One 2018; 13:e0191976. [PMID: 29373585 PMCID: PMC5786328 DOI: 10.1371/journal.pone.0191976] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2017] [Accepted: 01/15/2018] [Indexed: 11/29/2022] Open
Abstract
Vascular calcification is a strong and independent predictive factor for cardiovascular complications and mortality. Our previous work identified important discrepancies in plaque composition and calcification types between carotid and femoral arteries. The objective of this study is to further characterize and understand the heterogeneity in vascular calcification among vascular beds, and to identify molecular mechanisms underlying this process. We established ECLAGEN biocollection that encompasses human atherosclerotic lesions and healthy arteries from different locations (abdominal, thoracic aorta, carotid, femoral, and infrapopliteal arteries) for histological, cell isolation, and transcriptomic analysis. Our results show that lesion composition differs between these locations. Femoral arteries are the most calcified arteries overall. They develop denser calcifications (sheet-like, nodule), and are highly susceptible to osteoid metaplasia. These discrepancies may derive from intrinsic differences between SMCs originating from these locations, as microarray analysis showed specific transcriptomic profiles between primary SMCs isolated from each arterial bed. These molecular differences translated into functional disparities. SMC from femoral arteries showed the highest propensity to mineralize due to an increase in basal TGFβ signaling. Our results suggest that biological heterogeneity of resident vascular cells between arterial beds, reflected by our transcriptomic analysis, is critical in understanding plaque biology and calcification, and may have strong implications in vascular therapeutic approaches.
Collapse
Affiliation(s)
- Olivier Espitia
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
- CHU Hôtel Dieu, Nantes, France
| | - Mathias Chatelais
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - Marja Steenman
- Institut du Thorax, Inserm UMR1087, Faculté de Médecine, Université de Nantes, Nantes Atlantique Universités, Nantes, France
| | - Céline Charrier
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - Blandine Maurel
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
- CHU Hôtel Dieu, Nantes, France
| | - Steven Georges
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - Rémi Houlgatte
- Inserm U954, Faculty of Medicine, Nancy, France, DRCI, University Hospital of Nancy, Nancy, France
| | - Franck Verrecchia
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - Benjamin Ory
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - François Lamoureux
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
| | - Dominique Heymann
- Institut de Cancérologie de l'Ouest, site René Gauducheau, Boulevard Professeur Jacques Monod, Saint-Herblain, France
- University of Sheffield, Department of Oncology and Metabolism, INSERM, European Associated Laboratory “Sarcoma Research Unit”, Medical School, Sheffield, United Kingdom
- University of Nantes, Faculty of Medicine, Nantes, France
| | - Yann Gouëffic
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
- CHU Hôtel Dieu, Nantes, France
| | - Thibaut Quillard
- INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France
- CHU Hôtel Dieu, Nantes, France
- * E-mail:
| |
Collapse
|
5
|
Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21 + fibroblast progenitor cell transformation into adipocytes and vascular cells. Sci Rep 2017; 7:12804. [PMID: 29038558 PMCID: PMC5643307 DOI: 10.1038/s41598-017-13198-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2017] [Accepted: 09/19/2017] [Indexed: 01/10/2023] Open
Abstract
Cardiac fat tissue volume and vascular dysfunction are strongly associated, accounting for overall body mass. Despite its pathophysiological significance, the origin and autocrine/paracrine pathways that regulate cardiac fat tissue and vascular network formation are unclear. We hypothesize that adipocytes and vasculogenic cells in adult mice hearts may share a common cardiac cells that could transform into adipocytes or vascular lineages, depending on the paracrine and autocrine stimuli. In this study utilizing transgenic mice overexpressing prokineticin receptor (PKR1) in cardiomyocytes, and tcf21ERT-creTM-derived cardiac fibroblast progenitor (CFP)-specific PKR1 knockout mice (PKR1tcf−/−), as well as FACS-isolated CFPs, we showed that adipogenesis and vasculogenesis share a common CFPs originating from the tcf21+ epithelial lineage. We found that prokineticin-2 is a cardiomyocyte secretome that controls CFP transformation into adipocytes and vasculogenic cells in vivo and in vitro. Upon HFD exposure, PKR1tcf−/− mice displayed excessive fat deposition in the atrioventricular groove, perivascular area, and pericardium, which was accompanied by an impaired vascular network and cardiac dysfunction. This study contributes to the cardio-obesity field by demonstrating that PKR1 via autocrine/paracrine pathways controls CFP–vasculogenic- and CFP-adipocyte-transformation in adult heart. Our study may open up new possibilities for the treatment of metabolic cardiac diseases and atherosclerosis.
Collapse
|
6
|
Boezio B, Audouze K, Ducrot P, Taboureau O. Network-based Approaches in Pharmacology. Mol Inform 2017; 36. [PMID: 28692140 DOI: 10.1002/minf.201700048] [Citation(s) in RCA: 179] [Impact Index Per Article: 25.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2017] [Accepted: 06/21/2017] [Indexed: 12/23/2022]
Abstract
In drug discovery, network-based approaches are expected to spotlight our understanding of drug action across multiple layers of information. On one hand, network pharmacology considers the drug response in the context of a cellular or phenotypic network. On the other hand, a chemical-based network is a promising alternative for characterizing the chemical space. Both can provide complementary support for the development of rational drug design and better knowledge of the mechanisms underlying the multiple actions of drugs. Recent progress in both concepts is discussed here. In addition, a network-based approach using drug-target-therapy data is introduced as an example.
Collapse
Affiliation(s)
- Baptiste Boezio
- Université Paris Diderot - Inserm UMR-S973, MTi, 75205, Paris Cedex 13, 75013, Paris, France
| | - Karine Audouze
- Université Paris Diderot - Inserm UMR-S973, MTi, 75205, Paris Cedex 13, 75013, Paris, France
| | - Pierre Ducrot
- Institut de Recherche Servier, 125 Chemin de Ronde, 78290, Croissy-sur-Seine, France
| | - Olivier Taboureau
- Université Paris Diderot - Inserm UMR-S973, MTi, 75205, Paris Cedex 13, 75013, Paris, France
| |
Collapse
|
7
|
Zhao L, Fu HY, Raju R, Vishwanathan N, Hu WS. Unveiling gene trait relationship by cross-platform meta-analysis on Chinese hamster ovary cell transcriptome. Biotechnol Bioeng 2017; 114:1583-1592. [PMID: 28218403 DOI: 10.1002/bit.26272] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2016] [Revised: 01/17/2017] [Accepted: 02/15/2017] [Indexed: 12/15/2022]
Abstract
In the past few years, transcriptome analysis has been increasingly employed to better understand the physiology of Chinese hamster ovary (CHO) cells at a global level. As more transcriptome data accumulated, meta-analysis on data sets collected from various sources can potentially provide better insights on common properties of those cells. Here, we performed meta-analysis on transcriptome data of different CHO cell lines obtained using NimbleGen or Affymetrix microarray platforms. Hierarchical clustering, non-negative matrix factorization (NMF) analysis, and principal component analysis (PCA) accordantly showed the samples were clustered into two groups: one consists of adherent cells in serum-containing medium, and the other suspension cells in serum-free medium. Genes that were differentially expressed between the two clusters were enriched in a few functional classes by Database for Annotation, Visualization, and Integrated Discovery (DAVID) of which many were common with the enriched gene sets identified by Gene Set Enrichment Analysis (GSEA), including extracellular matrix (ECM) receptor interaction, cell adhesion molecules (CAMs), and lipid related metabolism pathways. Despite the heterogeneous sources of the cell samples, the adherent and suspension growth characteristics and serum-supplementation appear to be a dominant feature in the transcriptome. The results demonstrated that meta-analysis of transcriptome could uncover features in combined data sets that individual data set might not reveal. As transcriptome data sets accumulate over time, meta-analysis will become even more revealing. Biotechnol. Bioeng. 2017;114: 1583-1592. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Liang Zhao
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China
| | - Hsu-Yuan Fu
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota
| | - Ravali Raju
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota
| | - Nandita Vishwanathan
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota
| | - Wei-Shou Hu
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota
| |
Collapse
|
8
|
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients. Oncotarget 2016; 7:2367-78. [PMID: 26496024 PMCID: PMC4823041 DOI: 10.18632/oncotarget.6151] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2015] [Accepted: 09/30/2015] [Indexed: 12/30/2022] Open
Abstract
The identification of overexpressed miRNAs in multiple myeloma (MM) has progressively added a further level of complexity to MM biology. miRNA and gene expression profiles of two large representative MM datasets, available from retrospective and prospective series and encompassing a total of 249 patients at diagnosis, were analyzed by means of in silico integrative genomics methods, based on MAGIA2 and Micrographite computational procedures. We first identified relevant miRNA/transcription factors/target gene regulation circuits in the disease and linked them to biological processes. Members of the miR-99b/let-7e/miR-125a cluster, or of its paralog, upregulated in t(4;14), were connected with the specific transcription factors PBX1 and CEBPA and several target genes. These results were validated in two additional independent plasma cell tumor datasets. Then, we reconstructed a non-redundant miRNA-gene regulatory network in MM, linking miRNAs, such as let-7g, miR-19a, mirR-20a, mir-21, miR-29 family, miR-34 family, miR-125b, miR-155, miR-221 to pathways associated with MM subtypes, in particular the ErbB, the Hippo, and the Acute myeloid leukemia associated pathways.
Collapse
|
9
|
Kornegay JN, Spurney CF, Nghiem PP, Brinkmeyer-Langford CL, Hoffman EP, Nagaraju K. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J 2015; 55:119-49. [PMID: 24936034 DOI: 10.1093/ilar/ilu011] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked human disorder in which absence of the protein dystrophin causes degeneration of skeletal and cardiac muscle. For the sake of treatment development, over and above definitive genetic and cell-based therapies, there is considerable interest in drugs that target downstream disease mechanisms. Drug candidates have typically been chosen based on the nature of pathologic lesions and presumed underlying mechanisms and then tested in animal models. Mammalian dystrophinopathies have been characterized in mice (mdx mouse) and dogs (golden retriever muscular dystrophy [GRMD]). Despite promising results in the mdx mouse, some therapies have not shown efficacy in DMD. Although the GRMD model offers a higher hurdle for translation, dogs have primarily been used to test genetic and cellular therapies where there is greater risk. Failed translation of animal studies to DMD raises questions about the propriety of methods and models used to identify drug targets and test efficacy of pharmacologic intervention. The mdx mouse and GRMD dog are genetically homologous to DMD but not necessarily analogous. Subcellular species differences are undoubtedly magnified at the whole-body level in clinical trials. This problem is compounded by disparate cultures in clinical trials and preclinical studies, pointing to a need for greater rigor and transparency in animal experiments. Molecular assays such as mRNA arrays and genome-wide association studies allow identification of genetic drug targets more closely tied to disease pathogenesis. Genes in which polymorphisms have been directly linked to DMD disease progression, as with osteopontin, are particularly attractive targets.
Collapse
|
10
|
A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft. Kidney Int 2015; 87:984-95. [PMID: 25629549 PMCID: PMC4424816 DOI: 10.1038/ki.2014.395] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2014] [Revised: 10/02/2014] [Accepted: 10/23/2014] [Indexed: 01/21/2023]
Abstract
Patients tolerant to a kidney graft display a specific blood cell transcriptional pattern but results from five different studies were inconsistent, raising the question of relevance for future clinical application. To resolve this, we sought to identify a common gene signature, specific functional and cellular components, and discriminating biomarkers for tolerance following kidney transplantation. A meta-analysis of studies identified a robust gene signature involving proliferation of B and CD4 T cells, and inhibition of CD14 monocyte related functions among 96 tolerant samples. This signature was further supported through a cross-validation approach, yielding 92.5% accuracy independent of the study of origin. Experimental validation, performed on new tolerant samples and using a selection of the top-20 biomarkers, returned 91.7% of good classification. Beyond the confirmation of B-cell involvement, our data also indicated participation of other cell subsets in tolerance. Thus, the use of the top 20 biomarkers, mostly centered on B cells, may provide a common and standardized tool towards personalized medicine for the monitoring of tolerant or low-risk patients among kidney allotransplant recipients. These data point to a global preservation of genes favoring the maintenance of a homeostatic and ‘healthy' environment in tolerant patients and may contribute to a better understanding of tolerance maintenance mechanisms.
Collapse
|
11
|
Chen G, Broséus J, Hergalant S, Donnart A, Chevalier C, Bolaños-Jiménez F, Guéant JL, Houlgatte R. Identification of master genes involved in liver key functions through transcriptomics and epigenomics of methyl donor deficiency in rat: relevance to nonalcoholic liver disease. Mol Nutr Food Res 2014; 59:293-302. [PMID: 25380481 DOI: 10.1002/mnfr.201400483] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2014] [Revised: 09/17/2014] [Accepted: 10/26/2014] [Indexed: 02/06/2023]
Abstract
SCOPE Our study aims to investigate molecular events associated to methyl donor deficiency (MDD) by analyzing the transcriptome and the methylome of MDD rats in liver. METHODS AND RESULTS Twenty-one-day-old rats born to mothers fed either with a standard diet or a MDD diet during gestation and lactation were compared. From a total of 44 000 probes for 26 456 genes, we found two gene clusters in MDD rats whose expression levels had significant differences compared with controls: 3269 overexpressed (p < 0.0009) and 2841 underexpressed (p < 0.0004) genes. Modifications of DNA methylation were found in the promoter regions of 1032 genes out of 14 981 genes. Ontological analyses revealed that these genes are mainly involved in glucose and lipid metabolism, nervous system, coagulation, ER stress, and mitochondrial function. CONCLUSION Putative master genes exhibiting changes in both gene expression and DNA methylation are limited to 266 genes and are mainly involved in the renin-angiotensin system (n = 3), mitochondrion metabolism (n = 18), and phospholipid homeostasis (n = 3). Most of these master genes participate in nonalcoholic fatty liver disease. The adverse effects of MDD on the metabolic process indicate the beneficial impact of folate and vitamin B12, especially during the perinatal period.
Collapse
Affiliation(s)
- Gaili Chen
- Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine, Vandœuvre-lès-Nancy, France
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Calduch-Giner JA, Echasseriau Y, Crespo D, Baron D, Planas JV, Prunet P, Pérez-Sánchez J. Transcriptional assessment by microarray analysis and large-scale meta-analysis of the metabolic capacity of cardiac and skeletal muscle tissues to cope with reduced nutrient availability in Gilthead Sea Bream (Sparus aurata L.). MARINE BIOTECHNOLOGY (NEW YORK, N.Y.) 2014; 16:423-435. [PMID: 24626932 DOI: 10.1007/s10126-014-9562-3] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2013] [Accepted: 01/06/2014] [Indexed: 06/03/2023]
Abstract
The effects of nutrient availability on the transcriptome of cardiac and skeletal muscle tissues were assessed in juvenile gilthead sea bream fed with a standard diet at two feeding levels: (1) full ration size and (2) 70 % satiation followed by a finishing phase at the maintenance ration. Microarray analysis evidenced a characteristic transcriptomic profile for each muscle tissue following changes in oxidative capacity (heart > red skeletal muscle > white skeletal muscle). The transcriptome of heart and secondly that of red skeletal muscle were highly responsive to nutritional changes, whereas that of glycolytic white skeletal muscle showed less ability to respond. The highly expressed and nutritionally regulated genes of heart were mainly related to signal transduction and transcriptional regulation. In contrast, those of white muscle were enriched in gene ontology (GO) terms related to proteolysis and protein ubiquitination. Microarray meta-analysis using the bioinformatic tool Fish and Chips ( http://fishandchips.genouest.org/index.php ) showed the close association of a representative cluster of white skeletal muscle with some of cardiac and red skeletal muscle, and many GO terms related to mitochondrial function appeared to be common links between them. A second round of cluster comparisons revealed that mitochondria-related GOs also linked differentially expressed genes of heart with those of liver from cortisol-treated gilthead sea bream. These results show that mitochondria are among the first responders to environmental and nutritional stress stimuli in gilthead sea bream, and functional phenotyping of this cellular organelle is highly promising to obtain reliable markers of growth performance and well-being in this fish species.
Collapse
Affiliation(s)
- Josep A Calduch-Giner
- Nutrigenomics and Fish Growth Endocrinology Group, Instituto de Acuicultura Torre de la Sal (IATS-CSIC), Castellón, Spain
| | | | | | | | | | | | | |
Collapse
|
13
|
Bernardini C, Censi F, Lattanzi W, Calcagnini G, Giuliani A. Gene regulation networks in early phase of Duchenne muscular dystrophy. IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS 2013; 10:393-400. [PMID: 23929863 DOI: 10.1109/tcbb.2013.24] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The aim of this study was to analyze previously published gene expression data of skeletal muscle biopsies of Duchenne muscular dystrophy (DMD) patients and controls (gene expression omnibus database, accession #GSE6011) using systems biology approaches. We applied an unsupervised method to discriminate patient and control populations, based on principal component analysis, using the gene expressions as units and patients as variables. The genes having the highest absolute scores in the discrimination between the groups, were then analyzed in terms of gene expression networks, on the basis of their mutual correlation in the two groups. The correlation network structures suggest two different modes of gene regulation in the two groups, reminiscent of important aspects of DMD pathogenesis.
Collapse
|
14
|
Milnthorpe AT, Soloviev M. The use of EST expression matrixes for the quality control of gene expression data. PLoS One 2012; 7:e32966. [PMID: 22412959 PMCID: PMC3297614 DOI: 10.1371/journal.pone.0032966] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2011] [Accepted: 02/06/2012] [Indexed: 01/10/2023] Open
Abstract
EST expression profiling provides an attractive tool for studying differential gene expression, but cDNA libraries' origins and EST data quality are not always known or reported. Libraries may originate from pooled or mixed tissues; EST clustering, EST counts, library annotations and analysis algorithms may contain errors. Traditional data analysis methods, including research into tissue-specific gene expression, assume EST counts to be correct and libraries to be correctly annotated, which is not always the case. Therefore, a method capable of assessing the quality of expression data based on that data alone would be invaluable for assessing the quality of EST data and determining their suitability for mRNA expression analysis. Here we report an approach to the selection of a small generic subset of 244 UniGene clusters suitable for identification of the tissue of origin for EST libraries and quality control of the expression data using EST expression information alone. We created a small expression matrix of UniGene IDs using two rounds of selection followed by two rounds of optimisation. Our selection procedures differ from traditional approaches to finding "tissue-specific" genes and our matrix yields consistency high positive correlation values for libraries with confirmed tissues of origin and can be applied for tissue typing and quality control of libraries as small as just a few hundred total ESTs. Furthermore, we can pick up tissue correlations between related tissues e.g. brain and peripheral nervous tissue, heart and muscle tissues and identify tissue origins for a few libraries of uncharacterised tissue identity. It was possible to confirm tissue identity for some libraries which have been derived from cancer tissues or have been normalised. Tissue matching is affected strongly by cancer progression or library normalisation and our approach may potentially be applied for elucidating the stage of normalisation in normalised libraries or for cancer staging.
Collapse
Affiliation(s)
- Andrew T. Milnthorpe
- School of Biological Sciences, CBMS, Royal Holloway University of London, Egham, Surrey, United Kingdom
| | - Mikhail Soloviev
- School of Biological Sciences, CBMS, Royal Holloway University of London, Egham, Surrey, United Kingdom
| |
Collapse
|
15
|
Panagiotou G, Taboureau O. The impact of network biology in pharmacology and toxicology. SAR AND QSAR IN ENVIRONMENTAL RESEARCH 2012; 23:221-235. [PMID: 22352466 DOI: 10.1080/1062936x.2012.657237] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
With the need to investigate alternative approaches and emerging technologies in order to increase drug efficacy and reduce adverse drug effects, network biology offers a novel way of approaching drug discovery by considering the effect of a molecule and protein's function in a global physiological environment. By studying drug action across multiple scales of complexity, from molecular to cellular and tissue level, network-based computational methods have the potential to improve our understanding of the impact of chemicals in human health. In this review we present the available large-scale databases and tools that allow integration and analysis of such information for understanding the properties of small molecules in the context of cellular networks. With the recent advances in the omics area, global integrative approaches are necessary to cope with the massive amounts of data, and biomedical researchers are urged to implement new types of analyses that can lead to new therapeutic interventions with increased safety and efficacy compared with existing medications.
Collapse
Affiliation(s)
- G Panagiotou
- Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark
| | | |
Collapse
|
16
|
Baron D, Magot A, Ramstein G, Steenman M, Fayet G, Chevalier C, Jourdon P, Houlgatte R, Savagner F, Pereon Y. Immune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle. PLoS One 2011; 6:e26952. [PMID: 22096509 PMCID: PMC3212519 DOI: 10.1371/journal.pone.0026952] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2011] [Accepted: 10/06/2011] [Indexed: 01/12/2023] Open
Abstract
Duchenne Muscular Dystrophy (DMD) is a complex process involving multiple pathways downstream of the primary genetic insult leading to fatal muscle degeneration. Aging muscle is a multifactorial neuromuscular process characterized by impaired muscle regeneration leading to progressive atrophy. We hypothesized that these chronic atrophying situations may share specific myogenic adaptative responses at transcriptional level according to tissue remodeling. Muscle biopsies from four young DMD and four AGED subjects were referred to a group of seven muscle biopsies from young subjects without any neuromuscular disorder and explored through a dedicated expression microarray. We identified 528 differentially expressed genes (out of 2,745 analyzed), of which 328 could be validated by an exhaustive meta-analysis of public microarray datasets referring to DMD and Aging in skeletal muscle. Among the 328 validated co-expressed genes, 50% had the same expression profile in both groups and corresponded to immune/fibrosis responses and mitochondrial metabolism. Generalizing these observed meta-signatures with large compendia of public datasets reinforced our results as they could be also identified in other pathological processes and in diverse physiological conditions. Focusing on the common gene signatures in these two atrophying conditions, we observed enrichment in motifs for candidate transcription factors that may coordinate either the immune/fibrosis responses (ETS1, IRF1, NF1) or the mitochondrial metabolism (ESRRA). Deregulation in their expression could be responsible, at least in part, for the same transcriptome changes initiating the chronic muscle atrophy. This study suggests that distinct pathophysiological processes may share common gene responses and pathways related to specific transcription factors.
Collapse
|
17
|
Thieblemont C, Briere J, Mounier N, Voelker HU, Cuccuini W, Hirchaud E, Rosenwald A, Jack A, Sundstrom C, Cogliatti S, Trougouboff P, Boudova L, Ysebaert L, Soulier J, Chevalier C, Bron D, Schmitz N, Gaulard P, Houlgatte R, Gisselbrecht C. The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study. J Clin Oncol 2011; 29:4079-87. [PMID: 21947824 DOI: 10.1200/jco.2011.35.4423] [Citation(s) in RCA: 199] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
Purpose To evaluate the prognostic value of the cell of origin (COO) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBLC), prospectively treated by rituximab, dexamethasone, high-dose cytarabine, and cisplatin (R-DHAP) versus rituximab, ifosfamide, carboplatin, and etoposide and followed by intensive therapy plus autologous stem-cell transplantation on the Collaborative Trial in Relapsed Aggressive Lymphoma (CORAL) trial. Patients and Methods Among the 396 patients included on the trial, histologic material was available for a total of 249 patients at diagnosis (n = 189 patients) and/or at relapse (n = 147 patients), which included 87 matched pairs. The patient data were analyzed by immunochemistry for CD10, BCL6, MUM1, FOXP1, and BCL2 expression and by fluorescent in situ hybridization for BCL2, BCL6 and c-MYC breakpoints. The correlation with survival data was performed by using the log-rank test and the Cox model. Results Characteristics of immunophenotype and chromosomal abnormalities were statistically highly concordant in the matched biopsies. In univariate analysis, the presence of c-MYC gene rearrangement was the only parameter to be significantly correlated with a worse progression-free survival (PFS; P = .02) and a worse overall survival (P = .04). When treatment interaction was tested, the germinal center B (GCB) –like DLBCL that was based on the algorithm by Hans was significantly associated with a better PFS in the R-DHAP arm. In multivariate analysis, independent prognostic relevance was found for the GCB/non-GCB the Hans phenotype interaction treatment (P = .04), prior rituximab exposure (P = .0052), secondary age-adjusted International Prognostic Index (P = .039), and FoxP1 expression (P = .047). Confirmation was obtained by gene expression profiling in a subset of 39 patients. Conclusion COO remains a major and independent factor in relapsed/refractory DLBCL, with a better response to R-DHAP in GCB-like DLBCL. This needs confirmation by a prospective study.
Collapse
Affiliation(s)
- Catherine Thieblemont
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Josette Briere
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Nicolas Mounier
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Hans-Ullrich Voelker
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Wendy Cuccuini
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Edouard Hirchaud
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Andreas Rosenwald
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Andrew Jack
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Christer Sundstrom
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Sergio Cogliatti
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Philippe Trougouboff
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Ludmila Boudova
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Loic Ysebaert
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Jean Soulier
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Catherine Chevalier
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Dominique Bron
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Norbert Schmitz
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Philippe Gaulard
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Remi Houlgatte
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| | - Christian Gisselbrecht
- Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Hematology; Catherine Thieblemont, Josette Briere, INSERM U728, Institut Universitaire d'hématologie, Paris VII; Catherine Thieblemont, Josette Briere, Nicolas Mounier, Philippe Gaulard, Christian Gisselbrecht, Groupe d'Etude des Lymphomes de l'Adulte; Josette Briere, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Anatomie Pathologie; Wendy Cuccuini, Jean Soulier, Assistance Publique-Hôpitaux de Paris, Hôpital
| |
Collapse
|
18
|
High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies. PLoS One 2011; 6:e25181. [PMID: 21966449 PMCID: PMC3178625 DOI: 10.1371/journal.pone.0025181] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2011] [Accepted: 08/26/2011] [Indexed: 12/11/2022] Open
Abstract
Genetic investigations of X-linked intellectual disabilities have implicated the ARX (Aristaless-related homeobox) gene in a wide spectrum of disorders extending from phenotypes characterised by severe neuronal migration defects such as lissencephaly, to mild or moderate forms of mental retardation without apparent brain abnormalities but with associated features of dystonia and epilepsy. Analysis of Arx spatio-temporal localisation profile in mouse revealed expression in telencephalic structures, mainly restricted to populations of GABAergic neurons at all stages of development. Furthermore, studies of the effects of ARX loss of function in humans and animal models revealed varying defects, suggesting multiple roles of this gene during brain development. However, to date, little is known about how ARX functions as a transcription factor and the nature of its targets. To better understand its role, we combined chromatin immunoprecipitation and mRNA expression with microarray analysis and identified a total of 1006 gene promoters bound by Arx in transfected neuroblastoma (N2a) cells and in mouse embryonic brain. Approximately 24% of Arx-bound genes were found to show expression changes following Arx overexpression or knock-down. Several of the Arx target genes we identified are known to be important for a variety of functions in brain development and some of them suggest new functions for Arx. Overall, these results identified multiple new candidate targets for Arx and should help to better understand the pathophysiological mechanisms of intellectual disability and epilepsy associated with ARX mutations.
Collapse
|